ask our doctors

Vascular Eye Diseases

Get the facts on Vascular Eye Diseases treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Vascular Eye Diseases prevention, screening, research, statistics and other Vascular Eye Diseases related topics. We answer all your qestions about Vascular Eye Diseases.

Question: Where in India is the best Eye treatment/surgery done on NeoVascularMembrane with a consistantly high success? Male patient aged approx.70 years is suffering from "Low vision"-almost blindness.Disease is detected to be "Neo Vascular Membrane-Sub Retinal"which has affected his Rt.eye. His Lt.eye is also partially damaged and also has cataract. Where in India can we get the best treatment/surgery for the above type of disease? I need to know the name of the hospital/institute who has performed similar kind of treatments successfully and not on experimental basis.

Answer: Go to Chennai. They do one of the best eye surgeries in Regional Institute of Ophthalmology and Government Ophthalmic Hospital in Chennai. Or you could also try the Apollo Hospital in Sarita Vihar. It is the largest healthcare provider in Asia and the third largest in the world.


Vascular Eye Diseases News

OXiGENE to Present at BIO CEO & Investor Conference

MarketWatch (press release)
SOUTH SAN FRANCISCO, Calif., Feb 6, 2012 (GlobeNewswire via COMTEX) -- OXiGENE, Inc. /quotes/zigman/4149096/quotes/nls/oxgn OXGN +6.46% , a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, ...
 

Mississippi Press

Hospital foundation dinner Thursday to raise funds and honor survivors of ...
Contra Costa Times
 

Biotech Sector Shows No Signs of Slowing -- OXiGENE and Generex Poised for Growth

MarketWatch (press release)
OXiGENE is a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases. The Company's major focus is developing vascular disrupting agents that selectively disrupt abnormal blood vessels associated with ...
 

TIME

Early Success in a Human Embryonic Stem Cell Trial to Treat Blindness
TIME
 

VGX-100 Identified as Potential New Therapy for Improving Corneal Graft Survival

Sacramento Bee
Circadian (ASX: CIR; OTCQX: CKDXY) is a biologics drug developer focusing on cancer and 'front of the eye' disease therapies. It controls exclusive worldwide rights to a significant intellectual property portfolio around Vascular Endothelial Growth ...
 

Diabetes amputations drop, but disease expands

SouthCoastToday.com
By ANIKA CLARK The Centers for Disease Control and Prevention published good news recently for the nation's diabetic adults. In 2008, substantially fewer of them 40 and older received lower limb amputations than they had 12 years prior.
 

Local Cardiologist Discusses Risks, Symptoms of Heart Disease

OzarksFirst.com
Dr. Hawkins: I think heart health is really important because cardio-vascular disease remains the No. 1 cause of death in men and women in the United States and we need to make a dent in that. Question: Between heart disease and diabetes, locally, ...
 

The Associated Press

Gordie Howe's dementia fight personal and public
The Associated Press
 

Stem cells prevent blindness, suggests first-ever human trial

io9
Both diseases are characterized by the gradual degeneration of a layer of cells in the eye known as the retinal pigment epithelium (RPE). If you've ever dissected a calf's eye, you've seen the RPE ? it's the black-pigmented tissue lining the inside of ...
 

Lewiston Sun Journal

French Canadian genetic disorder can cause killer cholesterol levels in even ...
Bangor Daily News